From b551dfeea2949ed50df30c034ddfde4e2eae4a12 Mon Sep 17 00:00:00 2001 From: borja Date: Wed, 30 Oct 2024 14:45:18 +0100 Subject: [PATCH] Auto saved by Logseq --- pages/InCORNTD 2025___Application.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/pages/InCORNTD 2025___Application.md b/pages/InCORNTD 2025___Application.md index eff91a7d..24bf0056 100644 --- a/pages/InCORNTD 2025___Application.md +++ b/pages/InCORNTD 2025___Application.md @@ -2,5 +2,5 @@ - **Título**: Fixed dose albenzadole/ivermectin coformulation, an innovative tool to help countries achieve their NTD control goals in a post-donation era - **Description**: The fixed-dose coformulation of albendazole and ivermectin is the result of 10+ years of innovations carried out by African and European organizations working through public-private partnerships. This orodispersible, mango-flavoured tablet has already demonstrated safety and efficacy against soil-transmitted helminths in a pivotal trial, although its potential uses go beyond these parasites. - A fixed-dose combination of albendazole and ivermectin + The fixed-dose combination of albendazole and ivermectin provides a novel approach to - \ No newline at end of file